NPY and neuroendocrine neoplasm: This was consistent with previous studies implicating dysfunction of the NPY system in various inflammatory pathologies, including cardiovascular disease, and neuroendocrine tumors through distinct signaling pathways via their receptors (Y1R, Y5R)57,58,129–131.